Live lyophilized vaccine against newcastle disease (Strain BOR-74, VGNKI)

Indications

• Specific prevention of Newcastle disease
• Suitable for use in both disease-free and outbreak-affected farms

Description
A live lyophilized vaccine derived from the Newcastle disease virus strain "BOR-74" (produced by VGNKI).
The virus is cultivated in the allantoic fluid of SPF chicken embryos. The vaccine is suitable for all breeds of poultry, regardless of productivity level.

Target Animals:

• Poultry

Immunity and Dosage
Method of use: injections.
The vaccine is administered intranasally (or ocularly), orally via drinking water, by aerosol, or using coarse spray.
Each dose contains at least 6.0 log₁₀ EID₅₀.
Vaccination is administered when the antibody level is low:

• HA test (HI assay): titer < 1:8.
• ELISA: result less than twice the positive threshold.

Initial antibody screening is recommended at 7–10 days of age.